Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoral Products Regulatory News (CRU)

Share Price Information for Coral Products (CRU)

Share Price is delayed by 15 minutes
Get Live Data
5.25    0.00 (0.00%)
Bid:
5.00
Ask:
5.50
Spread: 0.50 (10.00%)
Market Cap: £4.66m
CRU Live PriceLast checked at - London Stock Exchange

Intraday Coral Products Share Chart

Correction Trading update - Q1 - 2020

24 Aug 2020 09:29

RNS Number : 9609W
Coral Products PLC
24 August 2020
 

The following amendment has been made to the 'Trading update - Q1 - 2020' announcement released on 24 August 2020 at 07:00am under RNS No 8704W.

 

The underlying operating profit (excluding finance expenses)* measure within the table should have read underlying operating profit*.

 

All other details remain unchanged. The full amended text is shown below.

 

Coral Products PLC

(the "Company" or "Coral")

 

Trading update - Q1 - 2020

 

Further to the update on 14 May 2020 the Board is pleased to provide an update for Q1-2020 (3 months to 31 July 2020).

As set out below underlying operating profit has increased significantly compared to Q1-2019. Underlying operating profit is ahead of management's budgeted expectations.

3 months to 31 July (unaudited)

Q1 -2020

Q1- 2019

Group Sales

£5.4m

£7.1m

Gross Margin

30.5%

27.3%

Underlying operating profit*

£201.5k

£38.4k

Underlying EBITDA*

£564.8k

£537.2k

 

\* The financial headlines disclosed as underlying represent the reported metrics excluding separately disclosed items see note 1 below.

The early actions taken by the Board to cut costs and improve efficiencies are reflected in the reported result.

These Q1-2020 results were despite a near 25% fall in sales in the comparative period in the previous year, all of which stems from the trading conditions surrounding Covid-19.

When sales return to historical levels, as and when Covid-19 begins to fade, then the contribution from the increased sales should further improve profitability.

Cash management remains a priority but with the receipt of the £1m Coronavirus Business Interruption Loan (notified 14 May 2020) the Company has significantly reduced creditor pressure whilst remaining within its agreed facilities and loan covenants.

The Board is confident, subject to the Covid-19 caveat below, that cash flow should further improve over the remainder of the financial year.

The prevailing uncertainties arising from the ongoing Covid-19 crisis and the danger of a secondary wave which could lead to further deterioration in trading conditions prevents the Board from giving any further guidance on the outcome for the current financial year.

Moulding and extrusions operations remain as previously disclosed in the Company's trading update of 14 May 2020.

Note 1 - Underlying profit before tax, underlying earnings per share, underlying operating profit, underlying earnings before interest, tax, depreciation and amortisation are defined as being before share based payment charges, amortisation of intangibles recognised on acquisition, acquisition costs, reorganisation costs, compensation for loss of office and impairment loss on trade receivables. Collectively these are referred to as separately disclosed items. In the opinion of the directors the disclosure of these transactions should be reported separately for a better understanding of the underlying trading performance of the Group.

 

This announcement contains inside information for the purpose of Article 7 of the EU Regulation 596/2014 and has been arranged for release by Sharon Gramauskas, Finance Director of the Company.

 

For further information, please contact:

Coral Products plc

Michael (Mick) Wood, Chief Executive Officer

 

 

Tel: 07788 565 154

 

Nominated Adviser & Broker

Cairn Financial Advisers LLP

Liam Murray

Tony Rawlinson

David Lawman (Corporate Broking)

 

Tel: 020 7213 0880

 

Capital Markets Consultants Limited

Richard Pearson

 

Tel: 07515 587 184

 

 

This announcement contains unaudited information and forward-looking statements that are based on current expectations or beliefs, as well as assumptions about future events. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts and undue reliance should not be placed on any such statement because they speak only as at the date of this document and are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results, and Coral's plans and objectives, to differ materially from those expressed or implied in the forward-looking statements. Coral undertakes no obligation to revise or update any forward-looking statement contained within this announcement, regardless of whether those statements are affected as a result of new information, future events or otherwise, save as required by law and regulations.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTVZLBLBVLLBBD
Date   Source Headline
20th Apr 20264:15 pmRNSDirector/PDMR Shareholding
20th Apr 202612:20 pmRNSTrading Update
16th Feb 20267:00 amRNSAcquisition of the assets of AAC Cyroma Limited
8th Jan 20267:00 amRNSHalf-year Financial Report
26th Nov 20254:45 pmRNSResult of AGM & Directorate Change
26th Nov 20257:00 amRNSAGM Statement
31st Oct 202512:00 pmRNSNotice of AGM and Posting of Annual Report
31st Oct 20257:00 amRNSFinal Results
28th Aug 20253:50 pmRNSTransaction in Own Shares
26th Aug 20257:00 amRNSTransaction in Own Shares
22nd Aug 20257:00 amRNSTransaction in Own Shares
10th Jul 20258:58 amRNSDirectorate Change
8th Jul 202510:08 amRNSIssue of Options
7th Jul 202510:08 amRNSFull Year Trading Update and Acquisition Update
30th May 20257:00 amRNSDirector/PDMR Shareholding
6th May 20257:00 amRNSDirectorate Change
4th Apr 20253:36 pmRNSDirector/PDMR Shareholding
3rd Apr 20252:15 pmRNSDirector/PDMR Shareholding
1st Apr 20253:50 pmRNSAcquisition of the assets of Arrow Film Converters
20th Mar 202511:00 amRNSIce Cream & Food Container three-year Agreement
4th Mar 20257:00 amRNSRenewal of Contract
27th Feb 202512:57 pmRNSDirector/PDMR Shareholding
26th Feb 202511:07 amRNSDirector/PDMR Shareholding
21st Feb 202511:02 amRNSDirector/PDMR Shareholding
17th Feb 20257:00 amRNSCompletion of Property Sale and Directorate Change
3rd Feb 20257:00 amRNSChange of Adviser
28th Jan 20254:35 pmRNSDirector/PDMR Shareholding
27th Jan 20257:00 amRNSHalf-year Report
7th Jan 20257:00 amRNSProperty Sales and Insurance Claim Settlement
4th Dec 20247:00 amRNSDirectorate Change
12th Nov 20247:00 amRNSDirectorate Change
25th Oct 20247:00 amRNSDirectorate Change
23rd Oct 20244:30 pmRNSResult of General Meeting
14th Oct 20247:00 amRNSTrading Statement
17th Sep 20247:00 amRNSFinal Results
24th Jul 20247:00 amRNSSale and Leaseback of Runcorn Factory Site
11th Jun 20247:00 amRNSTrading Statement
23rd May 20245:45 pmRNSTransaction in Own Shares
23rd May 20247:00 amRNSDirector/PDMR Shareholding
22nd May 20246:20 pmRNSTransaction in Own Shares
13th May 20244:30 pmRNSDirector/PDMR Shareholding
9th May 20242:50 pmRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSDirector/PDMR Shareholding
26th Jan 20247:00 amRNSTrading Statement
11th Dec 20237:00 amRNSHalf-year Report
29th Nov 20237:00 amRNSTrading Update and Directorate Change
7th Nov 20237:00 amRNSChange of Nominated Adviser and Broker
13th Oct 20235:21 pmRNSTransaction in Own Shares
12th Oct 20235:22 pmRNSTransaction in Own Shares
11th Oct 20235:52 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.